• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极低出生体重早产儿经导管动脉导管未闭封堵术:早期结果及中期随访

Transcatheter patent ductus arteriosus closure in very low birth weight preterm infants: early results and midterm follow-up.

作者信息

Liu Junhui, Gao Wei, Liu Zigang, Zhao Kun, Luo Gang, Gao Shuai, Sun Yi, Pan Silin

机构信息

Heart Center, Women and Children's Hospital, Qingdao University, Qingdao, China.

Cardiology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Front Pediatr. 2025 Jul 28;13:1650335. doi: 10.3389/fped.2025.1650335. eCollection 2025.

DOI:10.3389/fped.2025.1650335
PMID:40791805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12336215/
Abstract

BACKGROUND

Although transcatheter patent ductus arteriosus (PDA) closure is becoming increasingly common in very low birth weight (VLBW) preterm infants, several key issues remain controversial. These include identifying suitable patient characteristics, determining the optimal timing for PDA closure, preventing potential complications, and accurately assessing mid- and long-term outcomes. This study aims to summarize our preliminary experience in selecting appropriate patients and timing for PDA closure, and to report the early and mid-term outcomes of transcatheter PDA closure in VLBW preterm infants.

METHODS

This was a single-center retrospective study. Eligible participants included preterm infants with gestational age <37 weeks and birth weight <1,500 g who underwent transcatheter PDA closure between January 2024 and January 2025 at Qingdao Women and Children's Hospital. Data on patient characteristics, procedural age, PDA closure, survival, and intraoperative or postoperative complications were collected. Outcomes were assessed immediately after the procedure, at discharge, and 6 months post-discharge.

RESULTS

Procedures were performed in 8 VLBW preterm infants [median procedural age 23 days (range: 13-36 days), median procedural weight 1,350 g (range: 810-1,480 g), median PDA diameter 3.75 mm (range: 2.3-4.1 mm)]. The devices were Amplatzer Piccolo ( = 8). Procedures were successful in 100% and uneventful in 87.5% (7 of 8). One patient experienced mild left pulmonary artery compression intraoperatively, which resolved with device repositioning. 25% (2 of 8) patients experienced transient systemic hypertension within 24 h postoperatively, which resolved with diuretic and sedative treatment. No patients experienced ventilation or oxygenation failure, residual PDA, device malposition, or embolization. Survival to discharge was 100%. At 6-month follow-up, all patients were alive and well, without residual PDA, left pulmonary artery stenosis, and aortic coarctation.

CONCLUSIONS

The promising early and mid-term outcomes suggest that transcatheter PDA closure in VLBW preterm infants is feasible. Suitable patient characteristics, accurate PDA closure timing, and careful postoperative care are crucial determinants for procedural success. Future studies need to further expand the sample size and extend the follow-up period to evaluate the long-term efficacy and potential complications of this intervention.

摘要

背景

尽管经导管动脉导管未闭(PDA)封堵术在极低出生体重(VLBW)早产儿中越来越普遍,但几个关键问题仍存在争议。这些问题包括确定合适的患者特征、确定PDA封堵的最佳时机、预防潜在并发症以及准确评估中期和长期结局。本研究旨在总结我们在选择合适患者和PDA封堵时机方面的初步经验,并报告VLBW早产儿经导管PDA封堵术的早期和中期结局。

方法

这是一项单中心回顾性研究。符合条件的参与者包括2024年1月至2025年1月在青岛妇女儿童医院接受经导管PDA封堵术的孕周<37周且出生体重<1500g的早产儿。收集患者特征、手术年龄、PDA封堵情况、生存情况以及术中或术后并发症的数据。在术后立即、出院时和出院后6个月评估结局。

结果

对8例VLBW早产儿进行了手术[中位手术年龄23天(范围:13 - 36天),中位手术体重1350g(范围:810 - 1480g),中位PDA直径3.75mm(范围:2.3 - 4.1mm)]。使用的封堵器为Amplatzer Piccolo(n = 8)。手术成功率为100%,87.5%(8例中的7例)手术过程顺利。1例患者术中出现轻度左肺动脉受压,通过调整封堵器位置得以解决。25%(8例中的2例)患者术后24小时内出现短暂性系统性高血压,通过利尿和镇静治疗得以缓解。没有患者出现通气或氧合失败、PDA残余、封堵器位置不当或栓塞。出院生存率为100%。在6个月随访时,所有患者均存活且情况良好,无PDA残余、左肺动脉狭窄和主动脉缩窄。

结论

良好的早期和中期结局表明,VLBW早产儿经导管PDA封堵术是可行的。合适的患者特征、准确的PDA封堵时机以及精心的术后护理是手术成功的关键决定因素。未来的研究需要进一步扩大样本量并延长随访时间,以评估该干预措施的长期疗效和潜在并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81db/12336215/4c64b7cda82e/fped-13-1650335-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81db/12336215/4c64b7cda82e/fped-13-1650335-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81db/12336215/4c64b7cda82e/fped-13-1650335-g001.jpg

相似文献

1
Transcatheter patent ductus arteriosus closure in very low birth weight preterm infants: early results and midterm follow-up.极低出生体重早产儿经导管动脉导管未闭封堵术:早期结果及中期随访
Front Pediatr. 2025 Jul 28;13:1650335. doi: 10.3389/fped.2025.1650335. eCollection 2025.
2
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产和/或低出生体重婴儿的动脉导管未闭。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003481. doi: 10.1002/14651858.CD003481.pub3.
3
Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.早产儿血流动力学显著的动脉导管未闭的早期治疗与观察性管理
Cochrane Database Syst Rev. 2025 Jun 23;6(6):CD013278. doi: 10.1002/14651858.CD013278.pub3.
4
Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产儿和/或低出生体重儿的动脉导管未闭。
Cochrane Database Syst Rev. 2003(2):CD003481. doi: 10.1002/14651858.CD003481.
5
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.对早产儿或低出生体重儿的动脉导管未闭(patent ductus arteriosus),使用扑热息痛(acetaminophen,对乙酰氨基酚)。
Cochrane Database Syst Rev. 2022 Dec 15;12:CD010061. doi: 10.1002/14651858.CD010061.pub5.
6
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.对乙酰氨基酚(醋氨酚)用于早产儿或低出生体重儿动脉导管未闭。
Cochrane Database Syst Rev. 2018 Apr 6;4(4):CD010061. doi: 10.1002/14651858.CD010061.pub3.
7
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产和/或低出生体重婴儿的动脉导管未闭。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD003481. doi: 10.1002/14651858.CD003481.pub2.
8
Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.早治疗与期待治疗对早产儿有血流动力学意义的动脉导管未闭的效果比较。
Cochrane Database Syst Rev. 2020 Dec 10;12(12):CD013278. doi: 10.1002/14651858.CD013278.pub2.
9
Respiratory Outcomes After Transcatheter vs Surgical Patent Ductus Arteriosus Closure in Preterm Infants.早产儿经导管与外科手术关闭动脉导管未闭后的呼吸结局
JAMA Netw Open. 2025 Jun 2;8(6):e2513366. doi: 10.1001/jamanetworkopen.2025.13366.
10
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants.对乙酰氨基酚(扑热息痛)用于早产儿或低体重儿动脉导管未闭的治疗。
Cochrane Database Syst Rev. 2015 Mar 11(3):CD010061. doi: 10.1002/14651858.CD010061.pub2.

本文引用的文献

1
Procedural closure of the patent ductus arteriosus in preterm infants: a clinical practice guideline.早产儿动脉导管未闭的介入治疗:临床实践指南。
J Perinatol. 2024 Oct;44(10):1402-1408. doi: 10.1038/s41372-024-02052-9. Epub 2024 Jul 12.
2
Cardiorespiratory Instability after Percutaneous Patent Ductus Arteriosus Closure: A Multicenter Cohort Study.经皮动脉导管未闭封堵术后心肺不稳定:一项多中心队列研究。
J Pediatr. 2024 Aug;271:114052. doi: 10.1016/j.jpeds.2024.114052. Epub 2024 Apr 12.
3
Post-ligation cardiac syndrome after surgical versus transcatheter closure of patent ductus arteriosus in low body weight premature infants: a multicenter retrospective cohort study.
低体重早产儿经外科与经导管动脉导管未闭封堵术后结扎后心脏综合征:一项多中心回顾性队列研究。
Eur J Pediatr. 2024 May;183(5):2193-2201. doi: 10.1007/s00431-024-05481-y. Epub 2024 Feb 21.
4
3-year follow-up of a prospective, multicenter study of the Amplatzer Piccolo™ Occluder for transcatheter patent ductus arteriosus closure in children ≥ 700 grams.700 克以上儿童经导管动脉导管未闭封堵术的前瞻性多中心研究:Amplatzer Piccolo™ Occluder 的 3 年随访结果。
J Perinatol. 2023 Oct;43(10):1238-1244. doi: 10.1038/s41372-023-01741-1. Epub 2023 Aug 16.
5
Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews.早产儿动脉导管未闭(PDA)的干预措施:Cochrane 系统评价概述。
Cochrane Database Syst Rev. 2023 Apr 11;4(4):CD013588. doi: 10.1002/14651858.CD013588.pub2.
6
Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension.动脉导管未闭与支气管肺发育不良相关肺动脉高压的风险。
Pediatr Res. 2023 Aug;94(2):547-554. doi: 10.1038/s41390-023-02522-4. Epub 2023 Feb 17.
7
Changes in Patent Ductus Arteriosus Treatment Strategy and Respiratory Outcomes in Premature Infants.动脉导管未闭治疗策略的变化与早产儿呼吸系统结局的关系
J Pediatr. 2021 Aug;235:58-62. doi: 10.1016/j.jpeds.2021.04.030. Epub 2021 Apr 21.
8
Outcomes of Extremely Premature Infants Comparing Patent Ductus Arteriosus Management Approaches.比较动脉导管未闭管理方法对极度早产儿结局的影响。
J Pediatr. 2021 Aug;235:49-57.e2. doi: 10.1016/j.jpeds.2021.04.014. Epub 2021 Apr 20.
9
Patent ductus arteriosus, tracheal ventilation, and the risk of bronchopulmonary dysplasia.动脉导管未闭、气管通气与支气管肺发育不良的风险。
Pediatr Res. 2022 Feb;91(3):652-658. doi: 10.1038/s41390-021-01475-w. Epub 2021 Mar 31.
10
Conservative Non-intervention Approach for Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants.极低出生体重早产儿血流动力学显著的动脉导管未闭的保守非干预方法
Front Pediatr. 2020 Dec 23;8:605134. doi: 10.3389/fped.2020.605134. eCollection 2020.